These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

863 related articles for article (PubMed ID: 33919317)

  • 1. Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia.
    Albert K; Niskanen J; Kälvälä S; Lehtonen Š
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When glia meet induced pluripotent stem cells (iPSCs).
    Li L; Shi Y
    Mol Cell Neurosci; 2020 Dec; 109():103565. PubMed ID: 33068719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases.
    Bordoni M; Rey F; Fantini V; Pansarasa O; Di Giulio AM; Carelli S; Cereda C
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and immune dysfunction of glia in neurodegenerative disorders: Focus on iPSC models.
    Rõlova T; Lehtonen Š; Goldsteins G; Kettunen P; Koistinaho J
    Stem Cells; 2021 Mar; 39(3):256-265. PubMed ID: 33270954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality?
    Yousefi N; Abdollahii S; Kouhbanani MAJ; Hassanzadeh A
    J Cell Physiol; 2020 Dec; 235(12):9166-9184. PubMed ID: 32437029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
    Wu YY; Chiu FL; Yeh CS; Kuo HC
    Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies.
    Pazzin DB; Previato TTR; Budelon Gonçalves JI; Zanirati G; Xavier FAC; da Costa JC; Marinowic DR
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances of induced pluripotent stem cells application in neurodegenerative diseases.
    Amin N; Tan X; Ren Q; Zhu N; Botchway BOA; Hu Z; Fang M
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109674. PubMed ID: 31255650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of induced pluripotent stem cells in regenerative medicine: neurodegenerative diseases.
    Peng J; Zeng X
    Stem Cell Res Ther; 2011 Jul; 2(4):32. PubMed ID: 21861938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease.
    Young JE; Goldstein LSB
    Methods Mol Biol; 2023; 2561():105-133. PubMed ID: 36399267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
    Payne NL; Sylvain A; O'Brien C; Herszfeld D; Sun G; Bernard CC
    N Biotechnol; 2015 Jan; 32(1):212-28. PubMed ID: 24815224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of treating neurodegenerative disease with induced pluripotent stem cells.
    Pen AE; Jensen UB
    Acta Neurol Scand; 2017 Jan; 135(1):57-72. PubMed ID: 26748435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
    Machairaki V
    Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling neurodegenerative disease using brain organoids.
    Wray S
    Semin Cell Dev Biol; 2021 Mar; 111():60-66. PubMed ID: 32513498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases.
    Cao L; Tan L; Jiang T; Zhu XC; Yu JT
    Mol Neurobiol; 2015 Aug; 52(1):244-55. PubMed ID: 25146848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cells (iPSCs) as model to study inherited defects of neurotransmission in inborn errors of metabolism.
    Jung-Klawitter S; Opladen T
    J Inherit Metab Dis; 2018 Nov; 41(6):1103-1116. PubMed ID: 29980968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental Cell Models for Investigating Neurodegenerative Diseases.
    Evangelisti C; Ramadan S; Orlacchio A; Panza E
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.